Global Artemisinine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Artemisinine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.
Artemisinine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Artemisinine market is projected to reach US$ 78 million in 2034, increasing from US$ 62 million in 2022, with the CAGR of 3.3% during the period of 2024 to 2034. Demand from Injections and Tablets are the major drivers for the industry.
Global Artemisinin key players include KPC Pharmaceuticals, Kerui nanhai, Sanofi, Guangxi xiancaotang, etc. Global top four manufacturers hold a share over 65%.
Europe is the largest market, with a share about 45%, followed by India, and Africa, both have a share about 40 percent.
In terms of product, Extraction from Artemisia annua is the largest segment, with a share over 82%. And in terms of application, the largest application is Antimalarial Tablets, followed by Antimalarial Injections.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Artemisinine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Guilin Pharmaceutical
CAT KHANH
Novanat Bioresource
BEEPZ
KPC Pharmaceuticals
BIONEXX
Guangxi xiancaotang
Sanofi
Natural Bio-engineering
Kerui nanhai
Segment by Type
Extraction from Artemisia annua
Semisynthetic Artemisinine
Injections
Tablets
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Artemisinine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Artemisinine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Artemisinine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Artemisinine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Artemisinine introduction, etc. Artemisinine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Artemisinine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Artemisinine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Artemisinine market is projected to reach US$ 78 million in 2034, increasing from US$ 62 million in 2022, with the CAGR of 3.3% during the period of 2024 to 2034. Demand from Injections and Tablets are the major drivers for the industry.
Global Artemisinin key players include KPC Pharmaceuticals, Kerui nanhai, Sanofi, Guangxi xiancaotang, etc. Global top four manufacturers hold a share over 65%.
Europe is the largest market, with a share about 45%, followed by India, and Africa, both have a share about 40 percent.
In terms of product, Extraction from Artemisia annua is the largest segment, with a share over 82%. And in terms of application, the largest application is Antimalarial Tablets, followed by Antimalarial Injections.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Artemisinine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Guilin Pharmaceutical
CAT KHANH
Novanat Bioresource
BEEPZ
KPC Pharmaceuticals
BIONEXX
Guangxi xiancaotang
Sanofi
Natural Bio-engineering
Kerui nanhai
Segment by Type
Extraction from Artemisia annua
Semisynthetic Artemisinine
Segment by Application
Injections
Tablets
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Artemisinine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Artemisinine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Artemisinine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Artemisinine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Artemisinine introduction, etc. Artemisinine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Artemisinine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices